A brief, high-dose remifentanil infusion partially reverses neuropathic pain in a subgroup of post herpetic neuralgia patients
- 1 June 2017
- journal article
- clinical trial
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 40, 195-197
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Neuropathic pain: mechanisms and their clinical implicationsBMJ, 2014
- Treatment of neuropathic pain with the capsaicin 8% patch: Quantitative sensory testing (QST) in a prospective observational study identifies potential predictors of response to capsaicin 8% patch treatmentScandinavian Journal of Pain, 2013
- Assessment of patients with chronic painBritish Journal of Anaesthesia, 2013
- Erasure of a Spinal Memory Trace of Pain by a Brief, High-Dose Opioid AdministrationScience, 2012
- Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTIONPain, 2011
- Referral practices in patients suffering from non‐malignant chronic painEuropean journal of pain, 2010
- Models and Mechanisms of Hyperalgesia and AllodyniaPhysiological Reviews, 2009
- Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference valuesPain, 2006
- Mechanisms of Disease: mechanism-based classification of neuropathic pain—a critical analysisNature Clinical Practice Neurology, 2006
- The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgiaBrain, 1996